submit news    HOME | FEEDBACK  


- Bio/Medicine

- Chemicals

- Defense

- Drug Delivery

- Education

- Electronics

- Energy

- Events

- Grants

- Industry

- Investment

- Litigation

- Materials


- Nanofabrication

- Nanoparticles

- Nanotubes

- Optics

- Partnership

- Patent

- Products

- Quantum dots

- Research

- Smart Dust

- Software

- Browse by Month

- Current Shows

- Previous Shows

- Submit Events

Become A Nanotechwire Partner

FEI Company

Veeco Instruments

Nano Science and Technology Institute

National Nanotechnology Initiative

Nanotechnology at Zyvex

Want to see your Company or Organization listed above? Become A Nanotechwire Partner Today - click here



Saturday, October 11, 2008 | Bio/Medicine | 0 comments
Nanobubbles Deliver Targeted Cancer Drugs Using Ultrasound
Using a combination of polymers that respond to temperature, a research team at the University of Utah has developed a multifunctional nanoparticle that can image tumors using ultrasound and simultaneously deliver cell-damaging energy and anticancer drugs to those tumors

Saturday, October 11, 2008 | Bio/Medicine | 0 comments
Sensitive nanowire disease detectors made by Yale scientists
Yale scientists have created nanowire sensors coupled with simple microprocessor electronics that are both sensitive and specific enough to be used for point-of-care (POC) disease detection, according to a report in Nano Letters.

Sunday, September 28, 2008 | Bio/Medicine | 0 comments
Near Infrared Nanoparticles Shine A Bright Light On Cancer
A new imaging method for breast cancer has been developed by a team of scientists from Penn State Milton S. Hershey Medical Center and Penn State College of Medicine and the departments of Materials Science and Engineering and Physics at Penn State.

Sunday, September 28, 2008 | Bio/Medicine | 0 comments
Structural ‘snapshots’ of a protein implicated in Alzheimer’s disease
New experiments reveal detailed physical features of a protein thought to exacerbate the pathology of Alzheimer’s disease

Tuesday, September 23, 2008 | Bio/Medicine | 0 comments
Scientists develop new, more sensitive nanotechnology test for chemical DNA modifications
Researchers at The Johns Hopkins University School of Medicine in Baltimore have developed a novel test to screen for chemical modifications to DNA known as methylation. The technology potentially could be used both for early cancer diagnoses and for assessing patients' response to cancer therapies.

Monday, September 22, 2008 | Bio/Medicine | 0 comments
GE to Accelerate Development of Nanoparticle Based Imaging Agents to Diagnose Cancer and Heart Disease Earlier
GE’s imaging agents to enable more personalized therapies for patients

Sunday, September 21, 2008 | Bio/Medicine | 0 comments
Disposable ‘lab-on-a-chip’ may save costs and lives
Low-cost, disposable cartridges that would let doctors perform diagnostic tests at the point-of-care could speed up diagnosis and treatment while lowering costs. European researchers are rapidly closing in on that goal.

Monday, September 15, 2008 | Bio/Medicine | 0 comments
Nanomedical approach targets multiple cancer genes, shrinks tumors
Nanoparticles filled with a drug that targets two genes that trigger melanoma could offer a potential cure for this deadly disease, according to cancer researchers. The treatment, administered through an ultrasound device, demonstrates a safer and more effective way of targeting cancer-causing genes in cancer cells without harming normal tissue.

Monday, September 15, 2008 | Bio/Medicine | 0 comments
Study Provides Clues about How Cancer Cells Develop Resistance to Chemotherapy Drug
Researchers have shown that increased expression of a gene called SIRT1 in cancer cells plays a significant role in the development of resistance to the chemotherapy drug cisplatin.

Monday, September 15, 2008 | Bio/Medicine | 0 comments
Calando Pharmaceuticals Announces Next siRNA Therapeutic Candidate for Oncology
Calando Pharmaceuticals announces development of a second siRNA oncology therapeutic, CALAA-02, targeting HIF-2alpha

Sunday, September 14, 2008 | Bio/Medicine | 0 comments
Calando Pharmaceuticals Phase II Clinical Study Of Nanoparticle-Based Cancer Drug Opens to Patient Enrollment
Previous work with IT-101 suggests that twice monthly “maintenance doses” of IT-101 given after the patient’s standard chemotherapy may have minimal side effects, allowing for improved quality of life, and improved progression free survival.

Sunday, September 14, 2008 | Bio/Medicine | 0 comments
Golden Rods For medical applications: production of gold nanorods without the use of cytotoxic additives
Gold nanoparticles are under consideration for a number of biomedical applications, such as tumor treatment

Wednesday, September 03, 2008 | Bio/Medicine | 0 comments
MIT zooms in on malaria-infected cells
Work could aid in diagnostics, drug testing

Monday, September 01, 2008 | Bio/Medicine | 0 comments
Boise State Cancer Research Breakthrough May Be 'Magic Bullet' for Cancer Treatment
The interdisciplinary group of researchers applied emerging nanotechnology techniques to traditional cancer research to come up with a highly effective method for the preferential killing of cancer cells while leaving ordinary cells healthy.

Wednesday, August 27, 2008 | Bio/Medicine | 0 comments
University of Oklahoma Researchers Developing New Tool to Detect Cancer
A group of internationally known researchers is working to create a sensor to detect biomarker gases exhaled in the breath of a person with cancer.

More News: 

 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33 
 34  35  36  37  38  39  40  41  42  43  44  45  46  47 

- submit company
- submit news
- submit events
- advertise here

- More Events

Copyright © 2017 | Privacy Policy |